NDAINTRAVENOUSPOWDER
Approved
Dec 2016
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
4
Mechanism of Action
[see Microbiology ()].
Clinical Trials (4)
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)
Started Jan 2008
63 enrolled
Fungal Infection
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
Started Mar 2006
131 enrolled
Fungal Infection
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)
Started May 2004
16 enrolled
Fungal Infection
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
Started Aug 2003
13 enrolled
InfectionUnspecified Adult Solid Tumor, Protocol Specific
Loss of Exclusivity
LOE Date
Dec 21, 2032
82 months away
Patent Expiry
Dec 21, 2032
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 9636407 | Dec 21, 2032 | Product | — |